P02.02 PRELIMINARY CHARACTERIZATION OF THE IMMUNE RESPONSE IN GLIOBLASTOMA BEFORE AND AFTER FIRST-LINE THERAPY

BACKGROUND: Glioblastoma constitutes the most common primary malignant brain tumor in adults. Its aggressive disease course is mediated by a hitherto poorly understood interplay of rapid tumor progression and therapy-related effects. Crucial factors include - amongst hypoxia, angiogenesis, and other...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kiesel, B., Millesi, M., Berghoff, A.S., Hainfellner, J.A., Widhalm, G., Marosi, C., Höftberger, R., Haberler, C., Woehrer, A.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Poster Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185459/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.118
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars